Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study

Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study

BACKGROUND Field testing required to license the combined measles, mumps, and rubella (MMR) vaccine must take into account the current recommendation of the vaccine in Brazil: first dose at 12 months and second dose at 15 months of age in combination with a varicella vaccine. OBJECTIVES This stud...

Full description

Bibliographic Details
Main Authors: Eliane Matos dos Santos, Tatiana Guimarães Noronha, Isabelle Soares Alves, Robson Leite de Souza Cruz, Clara Lucy de Vasconcellos Ferroco, Ricardo Cristiano Brum, Patricia Mouta Nunes de Oliveira, Marilda Mendonça Siqueira, Mariza Cristina Lima, Francisco Luzio de Paula Ramos, Camila de Marco Bragagnolo, Luiz Antonio Bastos Camacho, Maria de Lourdes de Sousa Maia
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2019-03-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
vaccine
adverse events
measles
mumps
rubella
immunogenicity
safety
clinical trial
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100314&lng=en&tlng=en

Similar Items

Similar Items